Vanguard Group Inc Dare Bioscience, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,450,328 shares of DARE stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,450,328
Previous 3,448,612
0.05%
Holding current value
$1.48 Million
Previous $1.07 Million
58.09%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DARE
# of Institutions
37Shares Held
6.86MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA989KShares$425,4020.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny763KShares$328,0470.0% of portfolio
-
Black Rock Inc. New York, NY396KShares$170,3220.0% of portfolio
-
State Street Corp Boston, MA248KShares$106,5150.0% of portfolio
-
Northern Trust Corp Chicago, IL183KShares$78,8190.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $36.5M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...